£35k
Not reported the period beforeActive12167795Private limited companyLondon
ECS PHARMA LIMITED
Significant control: Francois Pierre Ferreira (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Ecs Pharma Limited sell?
Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
ECS PHARMA LIMITED is an active private limited company (company number 12167795) incorporated on 21 August 2019, registered in London. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest micro accounts cover the period ending 31 August 2025, showing net assets of £35k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
Peer position · net assets
By net assets it sits in the top quarter of 143 comparable companies in London (median £100, upper quartile £10k).
02
Ownership and control
- Mr Francois Pierre Ferreira
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 21 August 20197 yrs ago
- Next accounts due
- 31 May 2027in 219 days
- Confirmation statement due
- 4 September 2027in 315 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21100
- Manufacture of basic pharmaceutical products
- SIC 46460
- Wholesale of pharmaceutical goods
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
0
vs Aug 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 August 2025 | £35k | — | — | — | — | — | 0 |
| 31 August 2024 | — | — | — | — | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £35,344 at 31 August 2025
- Incorporated five or more years agoIncorporated 21 August 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 315 days
- Next accounts duein 219 days
- Accounts period endNet assets £35k · micro accounts
- Accounts period end
- Incorporated
08
Similar companies in London
- VITABIOTICS DISTRIBUTION LTDLondon · inc. Aug 2019
- NR PHARMA LTDLondon · inc. Sept 2019
- WORLD PHARMA LIMITEDLondon · inc. Sept 2019
- INNOPEUTICS LTDLondon · inc. Jul 2019
- INTERNATIONAL BIOPHARMA LIMITEDLondon · inc. Jul 2019
- BLUEPRINT MEDICINES (UK) LTD.London · inc. Jul 2019
All companies incorporated on 21 August 2019 · in Aug 2019.
09
Reminders for ECS PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.